Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1952
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P21-Activated Kinase Signaling in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2004English

P21 Protein (Cdc42 Rac)-Activated Kinase 1 (PAK1)

Science-Business eXchange
2011English

P21-Activated Kinase 1: PAK’ed With Potential

Oncotarget
Oncology
2011English

Targeting Core Signaling Pathways in Pancreatic Cancer

Science-Business eXchange
2008English

P21-Activated Kinase 1 Participates in Vascular Remodeling in Vitro and in Vivo

Hypertension
Internal Medicine
2010English

Neutron Crystallography: Opportunities, Challenges, and Limitations

Current Opinion in Structural Biology
Structural BiologyMolecular Biology
2008English

Molecular Pathways: The Balance Between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment

Clinical Cancer Research
Cancer ResearchOncology
2016English

665. miR-7 Inhibits Schwannoma Tumor Growth by Directly Targeting P21-Activated Kinase 1 and Epidermal Growth Factor Receptor

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

LKB1 Suppresses P21-Activated Kinase-1 (PAK1) by Phosphorylation of Thr109in the P21-Binding Domain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy